Wednesday, February 10, 2010, 4:58am EST - Canadian Markets open in 4 hours and 32 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Adolor Corp. (ADLR)

 On Feb 9: 1.46 USD   0.00 (0.00%)  
MORE ON ADLR
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Adolor Corporation (NGM:ADLR) Delayed quote dataEdit
Last Trade: 1.46 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 1.46
Open: N/A
Bid: 1.41 x 300
Ask: 1.69 x 300
1y Target Est: 2.90
Day's Range: N/A - N/A
52wk Range: 1.33 - 2.53
Volume: 0
Avg Vol (3m): 265,365
Market Cap: 67.65M
P/E (ttm): N/A
EPS (ttm): -1.21
Div & Yield: N/A (N/A%)
Adolor Corp. (ADLR)
1d  5d  3m  6m  1y  2y  5y  max 
 Add ADLR to Portfolio   Download Data

HEADLINES
• Adolor Corporation Announces Management Appointments
Business Wire (Thu, Jan 14)
• ADOLOR CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Officers
EDGAR Online (Mon, Dec 21)
• Adolor Corporation Initiates Clinical Testing in Opioid Bowel Dysfunction Program
Business Wire (Thu, Nov 12)
• ADOLOR CORP Financials
EDGAR Online Financials (Wed, Nov 4)
• ADOLOR CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Oct 30)
• Adolor Corporation Earnings Call scheduled for 8:45 am ET today
CCBN (Thu, Oct 29)
• ADOLOR CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Oct 29)
• This Partnership Will Go No Further
at Motley Fool (Thu, Oct 15)
• ADOLOR CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Wed, Sep 23)
• Pharmacoeconomic Analysis of Reported Use of ENTEREG(R) (alvimopan) Published in American Journal of Health-System Pharmacy
Marketwire (Thu, Aug 20)
More Headlines for ADLR...
ANALYST
EPS Est (next year) (Dec-09) : -1.08
EPS Est (in 2 years) (Dec-10) : -0.53
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Adolor Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of prescription pain management products.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices